Cargando…
Skin Autofluorescence, as Marker of Accumulation of Advanced Glycation Endproducts and of Cumulative Metabolic Stress, Is Not Increased in Patients with Systemic Sclerosis
Objective. To investigate whether advanced glycation endproducts (AGEs) in the skin are increased in patients with systemic sclerosis (SSc) and are related to the presence of disease-related and traditional cardiovascular risk factors. Methods. Skin autofluorescence, as a measure for the accumulatio...
Autores principales: | Hettema, M. E., Bootsma, H., Graaff, R., de Vries, R., Kallenberg, C. G. M., Smit, A. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184409/ https://www.ncbi.nlm.nih.gov/pubmed/21977038 http://dx.doi.org/10.1155/2011/417813 |
Ejemplares similares
-
Is skin autofluorescence (SAF) representative of dermal advanced glycation endproducts (AGEs) in dark skin? A pilot study
por: Atzeni, Isabella M., et al.
Publicado: (2020) -
Methylglyoxal-Derived Advanced Glycation Endproducts Accumulate in Multiple Sclerosis Lesions
por: Wetzels, Suzan, et al.
Publicado: (2019) -
The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes
por: Meerwaldt, Robbert, et al.
Publicado: (2008) -
Advanced glycation endproducts are increased in rheumatoid arthritis patients with controlled disease
por: de Groot, Lodewijk, et al.
Publicado: (2011) -
Methylglyoxal-Derived Advanced Glycation Endproducts in Multiple Sclerosis
por: Wetzels, Suzan, et al.
Publicado: (2017)